Materna Medical
Mountain View, US · Delaware corporation · 7 known investors
Materna Medical develops medical devices for women's pelvic health, including the FDA-cleared Milli vaginal dilator for treating vaginismus and painful intercourse, and the investigational Ellora System for labor support. The company serves women experiencing pelvic health challenges from conditions including menopause, postpartum recovery, cancer side effects, and sexual trauma.
Founders & leadership
Board
Investors · 7
Reported raises · per SEC filings
Form D private placements$45.8M disclosed across 4 rounds · 2016–2024
▶$10.8MraisedJun 2025 · 36 investors · Other Health CareRule 506(b)
- Michaela GriggsDirector
- Aileen StockburgerDirector
- Zaid Al-QaimiDirector
- Lisa GranickDirector
- Tracy MacNealExecutive Officer, Director
- Ariella GolombDirector
- Tim RiceDirector
- Offering amount
- $20M
- Amount sold
- $10.8M
- Minimum investment
- $1
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22MraisedJul 2022 · 14 investors · Other Health CareRule 506(b)
- Tim RiceDirector
- Ariella GolombDirector
- Lisa GranickDirector
- Aileen StockburgerDirector
- Michaela GriggsDirector
- Zaid Al-QaimiDirector
- Tracy MacNealExecutive Officer, Director
- Offering amount
- $22M
- Amount sold
- $22M
- Minimum investment
- $1
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.4MraisedApr 2021 · 53 investors · Other Health CareRule 506(b)
- Peter WylesDirector
- Zaid Al QaimiDirector
- Michaela GriggsDirector
- Tracy MacNealExecutive Officer, Director
- Arthur ReidelDirector
- Jim BochnowskiDirector
- Patrick JampDirector
- Offering amount
- $13.8M
- Amount sold
- $8.4M
- Minimum investment
- $1
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.6MraisedDec 2016 · 50 investors · Other Health CareRule 506(b)
- Art ReidelDirector
- Jim BochnowskiDirector
- Mark JuravicExecutive Officer, Director
- Ray JampDirector
- Offering amount
- $5.1M
- Amount sold
- $4.6M
- Minimum investment
- $1
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Materna Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $299.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Materna Medical do?
- Materna Medical develops medical devices for women's pelvic health, including the FDA-cleared Milli vaginal dilator for treating vaginismus and painful intercourse, and the investigational Ellora System for labor support. The company serves women experiencing pelvic health challenges from conditions including menopause, postpartum recovery, cancer side effects, and sexual trauma.
- Who are Materna Medical's investors?
- Materna Medical's investors include Azure Ventures Group, Band of Angels, Citrine Angels, Houston Angel Network, Texas HALO Fund, Golden Seeds, Wavemaker Three-Sixty Health.
- How much funding has Materna Medical raised?
- Materna Medical has disclosed $45.8M raised across 4 rounds.
- Where is Materna Medical headquartered?
- Materna Medical is headquartered in Mountain View, US.